Cargando…
Effect of human milk as a treatment for dry eye syndrome in a mouse model
PURPOSE: Dry eye syndrome (DES) affects millions of people worldwide. Homeopathic remedies to treat a wide variety of ocular diseases have previously been documented in the literature, but little systematic work has been performed to validate the remedies’ efficacy using accepted laboratory models o...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017541/ https://www.ncbi.nlm.nih.gov/pubmed/27667918 |
_version_ | 1782452766155735040 |
---|---|
author | Diego, Jose L. Bidikov, Luke Pedler, Michelle G. Kennedy, Jeffrey B. Quiroz-Mercado, Hugo Gregory, Darren G. Petrash, J. Mark McCourt, Emily A. |
author_facet | Diego, Jose L. Bidikov, Luke Pedler, Michelle G. Kennedy, Jeffrey B. Quiroz-Mercado, Hugo Gregory, Darren G. Petrash, J. Mark McCourt, Emily A. |
author_sort | Diego, Jose L. |
collection | PubMed |
description | PURPOSE: Dry eye syndrome (DES) affects millions of people worldwide. Homeopathic remedies to treat a wide variety of ocular diseases have previously been documented in the literature, but little systematic work has been performed to validate the remedies’ efficacy using accepted laboratory models of disease. The purpose of this study was to evaluate the efficacy of human milk and nopal cactus (prickly pear), two widely used homeopathic remedies, as agents to reduce pathological markers of DES. METHODS: The previously described benzalkonium chloride (BAK) dry eye mouse model was used to study the efficacy of human milk and nopal cactus (prickly pear). BAK (0.2%) was applied to the mouse ocular surface twice daily to induce dry eye pathology. Fluorescein staining was used to verify that the animals had characteristic signs of DES. After induction of DES, the animals were treated with human milk (whole and fat-reduced), nopal, nopal extract derivatives, or cyclosporine four times daily for 7 days. Punctate staining and preservation of corneal epithelial thickness, measured histologically at the end of treatment, were used as indices of therapeutic efficacy. RESULTS: Treatment with BAK reduced the mean corneal epithelial thickness from 36.77±0.64 μm in the control mice to 21.29±3.2 μm. Reduction in corneal epithelial thickness was largely prevented by administration of whole milk (33.2±2.5 μm) or fat-reduced milk (36.1±1.58 μm), outcomes that were similar to treatment with cyclosporine (38.52±2.47 μm), a standard in current dry eye therapy. In contrast, crude or filtered nopal extracts were ineffective at preventing BAK-induced loss of corneal epithelial thickness (24.76±1.78 μm and 27.99±2.75 μm, respectively), as were solvents used in the extraction of nopal materials (26.53±1.46 μm for ethyl acetate, 21.59±5.87 μm for methanol). Epithelial damage, as reflected in the punctate scores, decreased over 4 days of treatment with whole and fat-reduced milk but continued to increase in eyes treated with nopal-derived materials. CONCLUSIONS: Whole and fat-reduced human milk showed promising effects in the prevention of BAK-induced loss of corneal epithelial thickness and epithelial damage in this mouse model. Further studies are required to determine whether human milk may be safely used to treat dry eye in patients. |
format | Online Article Text |
id | pubmed-5017541 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Molecular Vision |
record_format | MEDLINE/PubMed |
spelling | pubmed-50175412016-09-23 Effect of human milk as a treatment for dry eye syndrome in a mouse model Diego, Jose L. Bidikov, Luke Pedler, Michelle G. Kennedy, Jeffrey B. Quiroz-Mercado, Hugo Gregory, Darren G. Petrash, J. Mark McCourt, Emily A. Mol Vis Research Article PURPOSE: Dry eye syndrome (DES) affects millions of people worldwide. Homeopathic remedies to treat a wide variety of ocular diseases have previously been documented in the literature, but little systematic work has been performed to validate the remedies’ efficacy using accepted laboratory models of disease. The purpose of this study was to evaluate the efficacy of human milk and nopal cactus (prickly pear), two widely used homeopathic remedies, as agents to reduce pathological markers of DES. METHODS: The previously described benzalkonium chloride (BAK) dry eye mouse model was used to study the efficacy of human milk and nopal cactus (prickly pear). BAK (0.2%) was applied to the mouse ocular surface twice daily to induce dry eye pathology. Fluorescein staining was used to verify that the animals had characteristic signs of DES. After induction of DES, the animals were treated with human milk (whole and fat-reduced), nopal, nopal extract derivatives, or cyclosporine four times daily for 7 days. Punctate staining and preservation of corneal epithelial thickness, measured histologically at the end of treatment, were used as indices of therapeutic efficacy. RESULTS: Treatment with BAK reduced the mean corneal epithelial thickness from 36.77±0.64 μm in the control mice to 21.29±3.2 μm. Reduction in corneal epithelial thickness was largely prevented by administration of whole milk (33.2±2.5 μm) or fat-reduced milk (36.1±1.58 μm), outcomes that were similar to treatment with cyclosporine (38.52±2.47 μm), a standard in current dry eye therapy. In contrast, crude or filtered nopal extracts were ineffective at preventing BAK-induced loss of corneal epithelial thickness (24.76±1.78 μm and 27.99±2.75 μm, respectively), as were solvents used in the extraction of nopal materials (26.53±1.46 μm for ethyl acetate, 21.59±5.87 μm for methanol). Epithelial damage, as reflected in the punctate scores, decreased over 4 days of treatment with whole and fat-reduced milk but continued to increase in eyes treated with nopal-derived materials. CONCLUSIONS: Whole and fat-reduced human milk showed promising effects in the prevention of BAK-induced loss of corneal epithelial thickness and epithelial damage in this mouse model. Further studies are required to determine whether human milk may be safely used to treat dry eye in patients. Molecular Vision 2016-09-09 /pmc/articles/PMC5017541/ /pubmed/27667918 Text en Copyright © 2016 Molecular Vision. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited, used for non-commercial purposes, and is not altered or transformed. |
spellingShingle | Research Article Diego, Jose L. Bidikov, Luke Pedler, Michelle G. Kennedy, Jeffrey B. Quiroz-Mercado, Hugo Gregory, Darren G. Petrash, J. Mark McCourt, Emily A. Effect of human milk as a treatment for dry eye syndrome in a mouse model |
title | Effect of human milk as a treatment for dry eye syndrome in a mouse model |
title_full | Effect of human milk as a treatment for dry eye syndrome in a mouse model |
title_fullStr | Effect of human milk as a treatment for dry eye syndrome in a mouse model |
title_full_unstemmed | Effect of human milk as a treatment for dry eye syndrome in a mouse model |
title_short | Effect of human milk as a treatment for dry eye syndrome in a mouse model |
title_sort | effect of human milk as a treatment for dry eye syndrome in a mouse model |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017541/ https://www.ncbi.nlm.nih.gov/pubmed/27667918 |
work_keys_str_mv | AT diegojosel effectofhumanmilkasatreatmentfordryeyesyndromeinamousemodel AT bidikovluke effectofhumanmilkasatreatmentfordryeyesyndromeinamousemodel AT pedlermichelleg effectofhumanmilkasatreatmentfordryeyesyndromeinamousemodel AT kennedyjeffreyb effectofhumanmilkasatreatmentfordryeyesyndromeinamousemodel AT quirozmercadohugo effectofhumanmilkasatreatmentfordryeyesyndromeinamousemodel AT gregorydarreng effectofhumanmilkasatreatmentfordryeyesyndromeinamousemodel AT petrashjmark effectofhumanmilkasatreatmentfordryeyesyndromeinamousemodel AT mccourtemilya effectofhumanmilkasatreatmentfordryeyesyndromeinamousemodel |